Perth-based biotechnology outfit BioPharmica plans to seek an initial public offer for its wholly owned subsidiary, Molecular Discovery Systems, which will focus on cancer treatments.

Perth-based biotechnology outfit BioPharmica plans to seek an initial public offer for its wholly owned subsidiary, Molecular Discovery Systems, which will focus on cancer treatments.